The playbook for bringing new drugs to market was just rewritten. In this episode, we break down the massive $2.1 billion valuation sweeping the AI drug discovery sector. We dive deep into the FDA’s major guidance update from last week, which outlines a historic shift toward Real-Time Clinical Trials (RTCT)—allowing regulators to stream trial data live from the cloud. Plus, we explore why global hyperscalers are throwing massive capital and compute into this new pharma infrastructure. If you want to understand how tech, big capital, and modern regulation are colliding to deliver cures faster than ever, this episode is a must-listen.